pISSN 1976-2283
eISSN 2005-1212

Download original image
Fig. 2. Cumulative incidence of depression during antiviral treatment with pegylated interferon α and ribavirin. The cumulative incidence rates of depression during antiviral therapy were 21.5% versus 21.5% at 12 weeks, 30.4% versus 27.2% at 24 weeks, 38.3% versus 34.2% at 36 weeks according to BDI-I (A) versus HADS-D (B), respectively.

BDI-I, Beck Depression Inventory-I; HADS-D, Hospital Anxiety and Depression scale-Depression; FU, follow-up; Pt., patients.

Gut and Liver 2017;11:426~433 https://doi.org/10.5009/gnl16242
© Gut and Liver